News Articles

Foxconn and Rockwell Automation Announce Partnership to Implement Industry-Leading IIoT Solutions at Foxconn’s... MILWAUKEE -Sunday, July 30th 2017 [ar]

(BUSINESS WIRE)-- Hon Hai Precision Industry Co., Ltd., also known as Foxconn, and Rockwell Automation announced today that they are collaborating to implement Connected Enterprise and Industrial Internet of Things (IIoT) concepts for smart manufacturing in Foxconn's new U.S. facilities. The...

Sagemcom Announces the Acquisition of Meter Italia S.p.A. RUEIL-MALMAISON, France -Sunday, July 30th 2017 [ar]

(BUSINESS WIRE)-- SAGEMCOM STRENGTHENS ITS POSITIONS ON THE MULTI-ENERGY MARKET, BY ACQUIRING METER ITALIA S.P.A, LEADER IN GAS METERING IN ITALY. As of July 27, 2017, Sagemcom becomes a 100% shareholder of Meter Italia S.p.A through its subsidiary Sagemcom Energy & Telecom SAS. Meter Italia...

Takeda Reports 1st Quarter FY2017 Results OSAKA, Japan -Saturday, July 29th 2017 [ar]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda's Growth Drivers Underlying Revenue grew +6.6% with growth across all regions (U.S. +13.5%, Japan +1.6%, Europe & Canada +4.6%, Emerging Markets +6.0%). Takeda's Growth...

IBC Announces Speaker Line Up for Audiences and Advertising Conference Stream LONDON -Saturday, July 29th 2017 [ar] [fr]  

(BUSINESS WIRE)-- IBC announces today the programme for the Audiences and Advertising Conference Stream, which will be held on Saturday 16th September. With broadcasters and media companies operating in an increasingly fragmented multi-platform TV market, the stream will explore where and how...

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the... BEERSE, Belgium -Friday, July 28th 2017 [ar]  

(BUSINESS WIRE)-- Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™...

Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and... INGELHEIM, Germany -Thursday, July 27th 2017

First patient enrolled into VOLTAIRE-X; an interchangeability study designed to assess whether BI 695501 is interchangeable with Humira®1 First study in the U.S. to investigate an interchangeability designation for an adalimumab biosimilar candidate BI 695501 is currently under review by...

Schlumberger Announces Second-Quarter 2017 Results  PARIS -Wednesday, July 26th 2017 [ar]

Revenue of $7.5 billion increased 8% sequentially Pretax operating income of $950 million increased 25% sequentially GAAP loss per share, including charges of $0.40 per share, was $0.05 EPS, excluding charges, was $0.35 Quarterly cash dividend of $0.50 per share was...

Nominum-led Panel Discussion at BlackHat Focuses on the Agility and Coverage Depth of DNS in Discovering and Blocking... REDWOOD CITY, Calif. -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- Nominum™, the DNS-based security and services innovation leader, announced today it is leading a panel discussion at BlackHat USA titled “DNS: An Agile Defense Against Diverse, Damaging Attacks.” The panel of speakers features security researcher Nick Feamster, Professor...

Visa Expands Global Transaction Processing with Facilities in Singapore and United Kingdom  SAN FRANCISCO -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- Visa (NYSE:V), a global payments technology company, today announced expanded transaction processing capabilities in two state-of-the-art data centers in Singapore and the United Kingdom. The new global processing hubs will increase the speed, resilience and geo-diversity of...

 ALTV Extends Launch of Hit Current Events Show ‘Street’s Point of View’ to Jordan after Success... AMMAN, Jordan -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- ALTV.com, one of the fastest growing free streaming services recently launched in the Middle East and North Africa, is bringing its hit show ‘Lel Share3 Weghet Nazar’, the Arabic transliteration of ‘Street’s Point of View’, to Jordanian audiences after attracting...

Mitsui Chemicals Starts Accepting Applications on September 1st for 2018 Mitsui Chemicals Catalysis Science Award TOKYO -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- Mitsui Chemicals Inc. (Location: Minato-ku, Tokyo; President & CEO: Tsutomu Tannowa) (TOKYO:4183) announced that Mitsui Chemicals Catalysis Science Award will begin accepting applications for the “2018 Mitsui Chemicals Catalysis Science Award” on September 1st via web site...

GSMA Announces First Details for Mobile World Congress 2018  LONDON -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- The GSMA today announced the first details of the 2018 Mobile World Congress, including exhibitors, sponsors, programmes and activities taking place at the annual mobile industry event. Under the theme “Creating a Better Future”, Mobile World Congress will be held 26...

Andersen Global Announces Collaboration with UnityFour and Pistiolis-Triantafyllos & Associates in Greece and... SAN FRANCISCO -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- Andersen Global is pleased to announce a new presence in Greece and Cyprus via a Collaboration Agreement with UnityFour and Pistiolis-Triantafyllos & Associates. Together, these firms provide legal, tax and accounting services in Greece; and tax, accounting and fiduciary...

Morpho Licence2Go: the Digital Licence Platform from OT-Morpho SYDNEY -Wednesday, July 26th 2017 [ar]

(BUSINESS WIRE)-- OT-Morpho, a world leader in digital security and identification technologies, has launched through its Australian subsidiary Morpho Australasia, an innovative solution for digital licences, aptly named Licence2Go. The platform allows the holders to dematerialize identification...

Janssen Announces Phase 3 Pivotal Study Results for Darunavir-Based Complete Treatment Regimen PARIS -Tuesday, July 25th 2017  

(BUSINESS WIRE)-- Janssen-Cilag International NV (Janssen) today announced that an investigational single-tablet regimen (STR) containing darunavir is effective and well tolerated. Results from the pivotal Phase 3 EMERALD study showed that a once-daily STR containing darunavir 800 mg, cobicistat...

Neustar Introduces New Integrated Security Platform STERLING, Va. -Tuesday, July 25th 2017

(BUSINESS WIRE)-- Neustar, Inc. (NYSE: NSR), a trusted, neutral provider of real-time information services, today introduced its new Integrated Security Platform, continuing to help organisations stay always on and ready to defend against security threats. Neustar helps enterprises not only...

Philip Morris International to Convert Cigarette Factory in Romania into Smoke-Free Product Facility LAUSANNE, Switzerland -Tuesday, July 25th 2017

Another step towards a smoke-free future €490 million planned investment. 300 new jobs to be created (BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) is planning to invest approximately €490 million to transform its cigarette production factory...

Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable... CORK, Ireland -Monday, July 24th 2017  

- Long-term data from the Phase 2b LATTE-2 study demonstrated comparable antiviral activity to daily, oral 3-drug combination - - Data presented as an oral late breaker at the 9th International AIDS Society Conference, 23-26 July 2017, Paris, France - (BUSINESS WIRE)-- Janssen Sciences...

Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive... PARIS, France -Monday, July 24th 2017

In Phase 1/2a APPROACH study, HIV-1 antibody response observed in all healthy volunteers Mosaic-based vaccine regimen is designed to elicit an immune response against a wide variety of HIV subtypes prevalent worldwide Positive clinical and preclinical results inform selection of lead...

People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey  INGELHEIM, Germany -Monday, July 24th 2017

• 61% of IPF patients are worried or extremely worried about experiencing an acute IPF exacerbation1 • Survey underlines the importance of appropriate support and coping mechanisms for patients living with IPF1 • Healthcare teams emphasise the need of a strong support network and...